Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
O-GlcNAcylation Rewires Wnt-Driven Bone Formation
2026-09-14
The reference study identifies O-GlcNAcylation as a necessary metabolic mediator of Wnt-stimulated osteogenesis rather than a passive consequence of increased glucose flux. Its central mechanism links Wnt3a to PDK1 Ser174 modification, PDK1 stabilization, enhanced aerobic glycolysis, and bone formation, with implications for fracture repair and anabolic osteoporosis research.
-
MitMAB for Organoid Endocytosis Research
2026-09-13
MitMAB provides a practical way to test whether extracellular-vesicle uptake depends on dynamin-driven vesicle scission. In polarized intestinal organoids, it helps connect uptake measurements with epithelial orientation, regional biology, barrier status, and intracellular trafficking research.
-
DAPI (hydrochloride) in Translational Cell Biology
2026-09-12
DAPI (hydrochloride), also known as 4',6-diamidino-2-phenylindole hydrochloride, is more than a routine nuclear counterstain. This article examines how its DNA-binding mechanism can strengthen translational studies of MPP7, epithelial–mesenchymal transition, cell polarity, and ovarian cancer while clarifying what the dye can—and cannot—prove.
-
Acetylcysteine for ROS/NF-κB Cell Assays
2026-09-12
Acetylcysteine enables controlled redox rescue experiments, from cochlear senescence assays to hepatic, respiratory, and neurodegenerative models. This workflow-focused guide explains how to select concentrations, separate antioxidant effects from toxicity, and translate NAC findings into defensible experimental decisions.
-
Fasudil and Hippo Signaling: A Translational ROCK Strategy
2026-09-11
Fasudil (HA-1077) HCl is more than a catalog ROCK inhibitor: it is a practical perturbation tool for separating cytoskeletal signaling, proliferation, migration, and apoptosis. By placing Fasudil alongside the 2025 quercetin–Hippo cataract study, this article defines a disciplined path from pathway observation to translational experiment without overstating cross-domain evidence.
-
Separating Caspase-6 Apoptosis from Pyroptosis
2026-09-11
A translational framework for using Z-VEID-FMK to distinguish caspase-6-dependent apoptosis from caspase-1-driven pyroptosis in neuronal and cancer models, informed by recent HOXC8 research in NSCLC.
-
Quercetin, Hippo Signaling, and Cataract Protection
2026-09-10
A 2025 study integrates network pharmacology, a UVB-induced cataract mouse model, and hydrogen peroxide-injured lens epithelial cells to investigate how quercetin protects the lens. Its findings link reduced oxidative stress and improved epithelial-cell survival to suppression of Hippo pathway activity, while pharmacologic pathway reactivation weakened these effects.
-
HEY2, Mitochondrial Respiration, and Cardiac Homeostasis
2026-09-10
The reference study identifies HEY2 as an inducible transcriptional brake on mitochondrial oxidative metabolism in cardiomyocytes. By combining disease-associated human samples with zebrafish, mouse, and cell-based perturbation models, it connects HEY2–HDAC1 repression of Ppargc1 and Cpt-related programs to reactive oxygen species, cardiomyocyte loss, and heart failure, while showing that targeted restoration of metabolic regulators can improve bioenergetic defects.
-
Influenza Hemagglutinin (HA) Peptide Workflow Guide
2026-09-09
Use the Influenza Hemagglutinin (HA) Peptide to release HA-tagged proteins from antibody capture systems under comparatively mild, tunable conditions. This practical guide covers immunoprecipitation, interaction studies, exosome-related assays, optimization, and troubleshooting.
-
BRCAness and Olaparib Sensitivity in Mesothelioma
2026-09-09
Borchert et al. connected homologous recombination repair gene-expression patterns with olaparib response in malignant pleural mesothelioma models. The study highlights BAP1-associated BRCAness as a potential basis for treatment stratification while identifying AURKA, RAD50, and DDB2 as prognostic candidates.
-
Small-Molecule Pancreatic Ductal Organoids
2026-09-08
The reference study presents a small-molecule cocktail strategy for improving the initiation, ductal enrichment, and long-term expansion of pancreatic ductal organoids. Its findings support a reproducible exocrine model that retains ductal and acinar heterogeneity and may be useful for pancreatic disease research and drug screening.
-
Morin, AMPD2, and Podocyte Energy Metabolism
2026-09-07
A 2025 study identifies excessive AMPD activity in the purine nucleotide cycle as a mechanistic link between fructose exposure, podocyte mitochondrial dysfunction, and glomerular injury. Using rat and MPC5 podocyte models, the authors show that Morin suppresses this metabolic disturbance and position AMPD2 as a potential target for further kidney research.
-
HA Tag Peptide as a Translational Mechanism Tool
2026-09-07
Translational researchers need more than pathway diagrams: they need reproducible ways to capture, release, and verify protein complexes. This article examines how the Influenza Hemagglutinin (HA) Peptide can support mechanistic studies of NEDD4L-mediated PRMT5 regulation while clarifying what the colorectal cancer evidence does—and does not—establish.
-
Engineering a Simpler Bitespiramycin Producer
2026-09-05
The reference study used an in-frame partial deletion of the sspA 3-O-acyltransferase gene to redirect Streptomyces spiramyceticus WSJ-1 toward production of 400-isovalerylspiramycin I with reduced component complexity. Its main contribution is a targeted biosynthetic-engineering strategy that separates pathway control from downstream susceptibility testing and offers a framework for improving antibiotic product consistency.
-
Y-27632 Dihydrochloride in Microfabricated Assays
2026-09-05
Y-27632 dihydrochloride is a selective ROCK inhibitor for dissecting how cytoskeletal signaling interacts with engineered cell environments. This guide presents a practical framework for combining pharmacological perturbation with rapid, microscope-enabled microfabrication while separating geometry effects from ROCK-dependent biology.